PACTR202404671084461招募中Unknown
Antenatal magnesium sulphate for short term neuroprotection among women at risk of preterm delivery at 28 to 36 weeks gestation.
Dr Linda James Audu0 个研究点目标入组 90 人开始时间: 2023年7月19日最近更新:
适应症
试验速览
- 阶段
- Unknown
- 状态
- 招募中
- 发起方
- 入组人数
- 90
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 19 Year(s) 至 44 Year(s)（—）
- 性别
- All
入选标准
- •Pregnant women at risk of preterm delivery between 28 to 36weeks of gestation
- •Preterm prelabour rupture of membranes
- •Preterm labour
- •Planned preterm birth for maternal or fetal indication
排除标准
- •Congenital anomaly in the foetus
- •Second stage of labour
- •Maternal hypotension
- •Women who received MgSO4 within the last 12 hrs
研究者
相似试验
尚未招募
不适用
Role of Magnesium suplhate to mother in protecting brain of preterm babiesCTRI/2018/06/014386PGIMS
进行中（未招募）
2 期
Magnesium sulfate as an adjuvant therapy in neonatal hypoxianeonatal hypoxiahypoxic ischemic encephalopathy S100-b magnesium sulfate neonatesTCTR20180720002Tanta university hospital60
进行中（未招募）
1 期
Does magnesium sulphate prevent cerebral palsy in very preterm born infants?EUCTR2011-000735-80-DKene Drasbek Huusom560
招募中
不适用
Magnesium sulphate ( magsalf) for fetal neuroprotection.CTRI/2019/05/019293King Georges Medical University
已完成
不适用
Magnesium sulphate for the treatment of pre-eclampsia: a trial to evaluate the effects on women and babiesPregnancy and ChildbirthPre-eclampsiaISRCTN86938761Medical Research Council (MRC) (UK)10,141